Kaye, Joel <br/><br/>
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  10 2016 
 - E6145-E6152 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1607843113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cytochrome P-450 CYP1A1--genetics<br/>Encephalomyelitis, Autoimmune, Experimental--drug therapy<br/>Female<br/>Gene Deletion<br/>Gene Expression<br/>Gene Expression Profiling<br/>Gene Expression Regulation--drug effects<br/>Hepatocytes--metabolism<br/>Humans<br/>Immune System--immunology<br/>Mice<br/>Mice, Knockout<br/>Quinolones--pharmacology<br/>Receptors, Aryl Hydrocarbon--agonists<br/>T-Lymphocytes--immunology<br/>Transcriptome